Background Data on cardiorespiratory fitness (CRF) in psoriatic arthritis (PsA) are scarce. This study aimed to determine the ...
Effect of mAb-3C on LCWE-induced vasculitis. Mice were injected intraperitoneally with PBS (n=7) or LCWE (n=14). After 2 weeks, LCWE-treated mice were further divided into two groups: no treatment ...
Berman A, Kenet G, Lubetsky A, et al. Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysis ...
It is evident that the morning symptoms of rheumatoid arthritis (RA) are linked to the circadian abnormal increase in night inflammation, favoured by inadequate cortisol secretion under conditions of ...
Objectives Multiple discontinuations of biologic (b-) or targeted synthetic (ts-) disease-modifying antirheumatic drugs (DMARDs) may indicate difficult-to-treat disease. We aimed to assess the ...
Knowledge of pathophysiology of rheumatoid arthritis (RA) has improved over the past decades, which resulted in new treatment options and strategies that led to better clinical outcomes. At the same ...
Correction: Distribution of nailfold videocapillaroscopy parameters in systemic lupus erythematosus and their association with disease activity: an international blinded case-control analysis on ...
We have evaluated the clinical value of the ELISA for anti-AT 1 R AAbs and anti-ET A R AAbs in two large, clinically well-defined cohorts of SSc patients from the Netherlands. Anti-AT 1 R AAbs and ...
Objective To determine the distribution of the EULAR SSc Impact of Disease (ScleroID) and its domain questions in very early (Ve), limited (lc) and diffuse cutaneous (dc) subsets, its value in ...
Intermetatarsal bursitis (IMB) is frequent in patients with rheumatoid arthritis (RA), but there are large discrepancies in the described prevalence and the most frequent localisations. Forty-three ...
Objectives Despite the clinical significance of neuropsychiatric systemic lupus erythematosus (NPSLE), which is a severe ...
Objective To summarise and update evidence to inform the 2022 update of the European Alliance of Associations of Rheumatology (EULAR) recommendations for the management of antineutrophil cytoplasmic ...